Crystallographic characterization of the PDZ1 domain of the human Na+/H+ exchanger regulatory factor.

The Na(+)/H(+) exchanger regulatory factor (NHERF) contains two PDZ domains that mediate the assembly of transmembrane and cytosolic proteins into functional signal transduction complexes. The human NHERF PDZ1 domain, which spans residues 11-99, interacts specifically with carboxy-terminal residues of the beta2 adrenergic receptor and the cystic fibrosis transmembrane conductance regulator. The NHERF PDZ1 was expressed in Escherichia coli as a soluble protein, purified and crystallized in the unbound form using the vapor-diffusion method with 2 M ammonium sulfate as the precipitant. Diffraction data were collected to 1.5 A resolution using synchrotron radiation. The crystals belong to space group P3(1)21 or P3(2)21, with unit-cell parameters a = b = 51.6, c = 58.9 A, and one molecule in the asymmetric unit.

[1]  G. Cutting,et al.  The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane. , 2000, The Journal of biological chemistry.

[2]  R. Huganir,et al.  PDZ domains in synapse assembly and signalling. , 2000, Trends in cell biology.

[3]  G. Kozlov,et al.  Solution structure of the PDZ2 domain from human phosphatase hPTP1E and its interactions with C-terminal peptides from the Fas receptor. , 2000, Biochemistry.

[4]  A. Bretscher,et al.  A kinase-regulated PDZ-domain interaction controls endocytic sorting of the β2-adrenergic receptor , 1999, Nature.

[5]  W. Lim,et al.  Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. , 1999, Science.

[6]  D. Bredt,et al.  PDZ Proteins Organize Synaptic Signaling Pathways , 1998, Cell.

[7]  P. Schatz,et al.  Peptide binding consensus of the NHE‐RF‐PDZ1 domain matches the C‐terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR) , 1998, FEBS letters.

[8]  S. Shenolikar,et al.  The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange , 1998, Nature.

[9]  J. Gusella,et al.  NHE-RF, a Regulatory Cofactor for Na+-H+Exchange, Is a Common Interactor for Merlin and ERM (MERM) Proteins* , 1998, The Journal of Biological Chemistry.

[10]  A. Bretscher,et al.  Identification of EBP50: A PDZ-containing Phosphoprotein that Associates with Members of the Ezrin-Radixin-Moesin Family , 1997, The Journal of cell biology.

[11]  C P Ponting,et al.  PDZ Domains: Targeting signalling molecules to sub‐membranous sites , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[12]  L. Cantley,et al.  Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains , 1997, Science.

[13]  R. Liddington,et al.  Crystal structure of a PDZ domain , 1996, Nature.

[14]  John H. Lewis,et al.  Crystal Structures of a Complexed and Peptide-Free Membrane Protein–Binding Domain: Molecular Basis of Peptide Recognition by PDZ , 1996, Cell.

[15]  S. Shenolikar,et al.  Characterization of a protein cofactor that mediates protein kinase A regulation of the renal brush border membrane Na(+)-H+ exchanger. , 1995, The Journal of clinical investigation.

[16]  S. Hubbard,et al.  Crystal structure of the tyrosine kinase domain of the human insulin receptor , 1994, Nature.

[17]  Sung-Hou Kim,et al.  Sparse matrix sampling: a screening method for crystallization of proteins , 1991 .

[18]  B. Matthews.  Solvent content of protein crystals. , 1968, Journal of molecular biology.

[19]  W. Bergsma-Schutter,et al.  Crystallization of Nucleic Acids and Proteins: A practical Approach , 1998 .

[20]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[21]  Wayne A Hendrickson,et al.  [28] Phase determination from multiwavelength anomalous diffraction measurements. , 1997, Methods in enzymology.